Browse Pet Safety Reports
15,484 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 15,484 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 15,484 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Nov 2, 2024 | Dog | Shepherd Dog - German | Bedinvetmab | Difficulty standing; Weakness; Unsteady gait | Outcome Unknown |
| Nov 1, 2024 | Dog | Collie - Border, Terrier - ... | Incurin | Limb weakness; Falling; Musculoskeletal disorder NOS | Ongoing |
| Nov 1, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Tremor; Ear infection NOS; Polydipsia; Behavioural disorder NOS; Limb weaknes... | Ongoing |
| Nov 1, 2024 | Dog | Collie - Border, Terrier - ... | Bedinvetmab | Limb weakness; Falling; Musculoskeletal disorder NOS | Ongoing |
| Nov 1, 2024 | Cat | Domestic Mediumhair | Cefovecin | Palpable mass NOS; Injection site sarcoma; Pulmonary metastases; Hemiparesis ... | Euthanized |
| Nov 1, 2024 | Dog | Rottweiler | Bedinvetmab | Limb weakness; Hind limb paresis | Recovered/Normal |
| Nov 1, 2024 | Dog | Sheepdog - Old English (Bob... | Bedinvetmab | Ataxia; Appetite loss; Muscle weakness NOS; Staring; Restlessness; Elevated l... | Ongoing |
| Nov 1, 2024 | Cat | Domestic Mediumhair | Robenacoxib | Palpable mass NOS; Injection site sarcoma; Pulmonary metastases; Hemiparesis ... | Euthanized |
| Nov 1, 2024 | Dog | Crossbred Canine/dog | Trilostane | Vomiting; Hearing decreased; Weakness; Hypercalcaemia; Elevated alanine amino... | Outcome Unknown |
| Nov 1, 2024 | Dog | Mountain Dog - Bernese, Ret... | Bedinvetmab | Not eating; Not drinking; Weakness | Outcome Unknown |
| Nov 1, 2024 | Dog | Great Pyrenees | Bedinvetmab | Limb weakness; Hind limb ataxia; Death by euthanasia | Euthanized |
| Nov 1, 2024 | Dog | Crossbred Canine/dog | Afoxolaner | Diarrhoea; Ataxia; Lethargy (see also Central nervous system depression in Ne... | Recovered/Normal |
| Nov 1, 2024 | Dog | Akita, Great Pyrenees | Potassium Bromide | Incoordination; Limb weakness; Lethargy (see also Central nervous system depr... | Outcome Unknown |
| Nov 1, 2024 | Dog | Greater Swiss Mountain Dog | Bedinvetmab | Limb weakness | Ongoing |
| Oct 31, 2024 | Dog | Shepherd Dog - German | Bedinvetmab | Appetite loss; Not drinking; Walking difficulty; Limb weakness; Head tilt - n... | Euthanized |
| Oct 29, 2024 | Dog | Deutsche Dogge, Great Dane | Bedinvetmab | Weakness; Proprioception deficit; Walking difficulty; Hind limb paralysis | Ongoing |
| Oct 29, 2024 | Dog | Dog (unknown) | Bedinvetmab | Lethargy (see also Central nervous system depression in Neurological); Diffic... | Ongoing |
| Oct 28, 2024 | Dog | Poodle - Standard | Bedinvetmab | Vestibular disorder NOS; Weakness; Walking difficulty; Eye disorder NOS (for ... | Ongoing |
| Oct 27, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Difficulty to rise; Vocalisation; Walking difficulty; Limb weakness; Paresis;... | Euthanized |
| Oct 26, 2024 | Dog | Spaniel - Cocker American, ... | Fluralaner 13.64% 12-Week Chew | Unable to jump; Muscle wasting; Hind limb ataxia; Limb weakness | Outcome Unknown |
| Oct 26, 2024 | Cat | Domestic Shorthair | Frunevetmab | Hind limb ataxia; Unable to walk; Limb weakness | Ongoing |
| Oct 26, 2024 | Dog | Retriever - Golden | Bedinvetmab | Limb weakness; Difficulty going up/down stairs; Lethargy (see also Central ne... | Outcome Unknown |
| Oct 26, 2024 | Dog | Retriever - Golden | Florfenicol; Mometasone Furoate; Terb... | Limb weakness; Ataxia; Facial paralysis; Head tilt - neurological disorder (s... | Recovered with Sequela |
| Oct 26, 2024 | Dog | Deutsche Dogge, Great Dane | Bedinvetmab | Ataxia; Limb weakness; Lumbar pain; Limb non-weight bearing | Ongoing |
| Oct 26, 2024 | Dog | Pug | Bedinvetmab | Limb weakness; Proprioception deficit; Hind limb paralysis; Unable to walk | Ongoing |
| Oct 26, 2024 | Dog | Boxer (German Boxer), Dog (... | Bedinvetmab | Decreased appetite; Lack of efficacy - NOS; Lethargy (see also Central nervou... | Ongoing |
| Oct 25, 2024 | Dog | Retriever - Golden | Bedinvetmab | Knuckling; Difficulty to rise; Limb weakness | Ongoing |
| Oct 25, 2024 | Dog | Japanese Chin (Spaniel) | Carprofen | Weakness; Laboured breathing; Lethargy (see also Central nervous system depre... | Ongoing |
| Oct 25, 2024 | Dog | Portuguese Water Dog | Bedinvetmab | Drooling; Not himself/herself; Vomiting foam; Not eating; Cough; Decreased bo... | Ongoing |
| Oct 24, 2024 | Dog | Beagle, Dog (unknown) | Trilostane | Lethargy (see also Central nervous system depression in Neurological); Limb w... | Outcome Unknown |
| Oct 24, 2024 | Dog | Retriever - Labrador, Poodl... | Phenylpropropanolamine Hcl | Stumbling gait; Limb weakness; Limb non-weight bearing; Elevated renal parame... | Outcome Unknown |
| Oct 23, 2024 | Dog | Shepherd Dog - German | Bedinvetmab | Lameness; Limb weakness; Hind limb ataxia; Proprioception deficit; Hyperexten... | Ongoing |
| Oct 23, 2024 | Dog | Crossbred Canine/dog | Bedinvetmab | Unable to stand; Limb weakness; Depressed reflexes | Ongoing |
| Oct 23, 2024 | Dog | Boxer (German Boxer), Dog (... | Bedinvetmab | Weakness; Unable to stand | Ongoing |
| Oct 23, 2024 | Dog | Retriever - Labrador, Dog (... | Bedinvetmab | Collapse NOS (see also Cardio-vascular and Neurological disorders); Limb weak... | Ongoing |
| Oct 23, 2024 | Dog | Dog (unknown) | Bedinvetmab | Limb weakness; Death by euthanasia | Euthanized |
| Oct 23, 2024 | Dog | Retriever - Labrador, Dog (... | Bedinvetmab | Limb weakness; Musculoskeletal disorder NOS | Ongoing |
| Oct 23, 2024 | Dog | Boxer (German Boxer) | Galliprant | Weakness; Unable to stand | Ongoing |
| Oct 22, 2024 | Dog | Dog (other) | Trilostane | Hypocortisolaemia; Excessive appetite; Breathlessness; Weakness; Uncomfortabl... | Outcome Unknown |
| Oct 22, 2024 | Dog | Dog (unknown) | Bedinvetmab | Difficulty standing; Limb weakness | Outcome Unknown |
| Oct 22, 2024 | Dog | Retriever (unspecified) | Bedinvetmab | Panting; Pacing; Uncomfortable; Limb weakness; Hypertension | Ongoing |
| Oct 22, 2024 | Dog | Crossbred Canine/dog | Bedinvetmab | Weakness; Urinary incontinence; Lethargy (see also Central nervous system dep... | Ongoing |
| Oct 21, 2024 | Dog | Crossbred Canine/dog | Bedinvetmab | Weakness; Muscle atrophy (see also Muscle wasting); Localised pain NOS (see o... | Ongoing |
| Oct 21, 2024 | Dog | Retriever - Labrador | Grapiprant | Wobbliness; Difficulty to rise; Arched back; Limb weakness; Proprioception de... | Ongoing |
| Oct 21, 2024 | Dog | Pug | Bedinvetmab | Weakness; Impaired proprioception; Unsteady gait; Muscle wasting | Ongoing |
| Oct 21, 2024 | Dog | Boxer (German Boxer) | Bedinvetmab | Not eating; Increased drinking; Polyuria; Weight loss; Excessive ear wax; Wob... | Ongoing |
| Oct 21, 2024 | Dog | Terrier - Yorkshire | Bedinvetmab | Walking difficulty; Limb weakness; Medication error NOS; Overdose | Ongoing |
| Oct 21, 2024 | Cat | Domestic Shorthair | Nitenpyram | Generalised weakness; Unable to walk; Wobbliness | Outcome Unknown |
| Oct 21, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Wobbliness; Difficulty to rise; Arched back; Limb weakness; Proprioception de... | Ongoing |
| Oct 21, 2024 | Cat | Domestic Shorthair | Nitenpyram | Generalised weakness; Unable to walk; Wobbliness; Shaking; Seizure NOS; Foami... | Died |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.